During the past decade, Laurentius Ziekenhuis conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laurentius Ziekenhuis" #1 sponsor was "Maastricht University Medical Center" with 8 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Radboud University Medical Center" with 4 trials sponsored, "Borstkanker Onderzoek Groep" with 3 trials sponsored and "Dutch Colorectal Cancer Group" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laurentius Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 6 trials as a collaborator, "Maastricht University" with 4 trials as a collaborator, "Dutch Cancer Society" with 3 trials as a collaborator, "Nordic Lymphoma Group" with 3 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Laurentius Ziekenhuis" are "Colorectal Cancer" (4 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (3 trials), "Kidney Failure, Chronic" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Laurentius Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Laurentius Ziekenhuis" are "Drug" (20 trials), "Procedure" (10 trials), "Other" (4 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "fluorouracil" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.

The vast majority of trials in "Laurentius Ziekenhuis" are 31 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Laurentius Ziekenhuis". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Laurentius Ziekenhuis, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Laurentius Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".